Trials / Unknown
UnknownNCT00164086
Atorvastatin in Myeloma
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Bayside Health · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to study the effects of a medication already widely used to treat cardiovascular disease and diabetes, in reducing the progression of myeloma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | atorvastatin |
Timeline
- First posted
- 2005-09-14
- Last updated
- 2006-10-11
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT00164086. Inclusion in this directory is not an endorsement.